However, on the same day, Citi reiterated a Hold rating on Cardinal Health (NYSE: CAH). The company has a one-year high of $126.23 and a one-year low of $93.17. Currently, Cardinal Health has an ...

The FDA approval of crinecerfont (Crenessity; Neurocrine Biosciences) on December 13, 2024, marked a significant milestone in the management of classic congenital adrenal hyperplasia (CAH), ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Achieving those goals is made easier with the Zacks Style Scores, a unique set ...

and pharmacokinetics of atumelnant when administered for 12 weeks in people with CAH caused by 21-hydroxylase deficiency. The study enrolled 28 patients across 3 dose cohorts with classic CAH on a ...

When Apple unveils its iPhone 17 suite of handsets in the fall, it looks like there’ll be one that’s different from anything that’s gone before. Nicknamed the iPhone 17 Air or iPhone 17 Slim ...